AR225346A1 - Procedimiento para preparar sales de 4'-(9-acridinilamino)metansulfon-c-anisidida - Google Patents

Procedimiento para preparar sales de 4'-(9-acridinilamino)metansulfon-c-anisidida

Info

Publication number
AR225346A1
AR225346A1 AR284565A AR28456581A AR225346A1 AR 225346 A1 AR225346 A1 AR 225346A1 AR 284565 A AR284565 A AR 284565A AR 28456581 A AR28456581 A AR 28456581A AR 225346 A1 AR225346 A1 AR 225346A1
Authority
AR
Argentina
Prior art keywords
metansulfon
acridinylamine
anisidide
salts
preparing
Prior art date
Application number
AR284565A
Other languages
English (en)
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of AR225346A1 publication Critical patent/AR225346A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/033Uronic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals
    • C07H7/027Keto-aldonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR284565A 1980-03-11 1981-03-10 Procedimiento para preparar sales de 4'-(9-acridinilamino)metansulfon-c-anisidida AR225346A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12950380A 1980-03-11 1980-03-11

Publications (1)

Publication Number Publication Date
AR225346A1 true AR225346A1 (es) 1982-03-15

Family

ID=22440294

Family Applications (1)

Application Number Title Priority Date Filing Date
AR284565A AR225346A1 (es) 1980-03-11 1981-03-10 Procedimiento para preparar sales de 4'-(9-acridinilamino)metansulfon-c-anisidida

Country Status (16)

Country Link
EP (1) EP0035862B1 (ja)
JP (1) JPS56142265A (ja)
KR (1) KR840001561B1 (ja)
AR (1) AR225346A1 (ja)
AT (1) ATE7911T1 (ja)
AU (1) AU535610B2 (ja)
CA (1) CA1253160A (ja)
DE (1) DE3164054D1 (ja)
DK (1) DK161072C (ja)
ES (1) ES8202332A1 (ja)
HU (1) HU183357B (ja)
IE (1) IE50967B1 (ja)
MX (1) MX6764E (ja)
NZ (1) NZ196461A (ja)
SU (1) SU1192619A3 (ja)
ZA (1) ZA811304B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322424A (en) * 1980-01-24 1982-03-30 Bristol-Myers Company Crystalline glucoconate salt of m-AMSA and compositions containing same
ES512969A0 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
DE3809814C1 (en) * 1988-03-23 1989-09-07 Karl Heinz Dr.Med. 7100 Heilbronn De Thiel Use of aminoacridines for iontophoretic treatment of bladder cancer
CA3209229A1 (en) * 2017-11-09 2019-05-16 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compounds for inhibiting ly6k and methods of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
DE3063905D1 (en) * 1979-09-14 1983-07-28 New Zealand Dev Finance Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
JPS5687566A (en) * 1979-11-30 1981-07-16 Bristol Myers Co Anticancerous composition
ZA81420B (en) * 1980-01-24 1982-02-24 Bristol Myers Co Antitumor compositions

Also Published As

Publication number Publication date
KR830005149A (ko) 1983-08-03
ZA811304B (en) 1982-06-30
ATE7911T1 (de) 1984-06-15
ES500228A0 (es) 1982-01-16
MX6764E (es) 1986-06-30
JPH0343269B2 (ja) 1991-07-01
ES8202332A1 (es) 1982-01-16
EP0035862A3 (en) 1981-11-18
HU183357B (en) 1984-04-28
EP0035862B1 (en) 1984-06-13
AU535610B2 (en) 1984-03-29
SU1192619A3 (ru) 1985-11-15
DE3164054D1 (en) 1984-07-19
JPS56142265A (en) 1981-11-06
IE810396L (en) 1981-09-11
NZ196461A (en) 1982-12-21
IE50967B1 (en) 1986-08-20
EP0035862A2 (en) 1981-09-16
DK161072C (da) 1991-11-11
AU6819281A (en) 1981-09-17
DK161072B (da) 1991-05-27
CA1253160A (en) 1989-04-25
DK109181A (da) 1981-09-12
KR840001561B1 (ko) 1984-10-05

Similar Documents

Publication Publication Date Title
AR231137A1 (es) Procedimiento para preparar metoxifenetilimidazoles
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES529728A0 (es) Procedimiento para preparar amino-2-fenil-5-benzodiazepinas-1, 3
MX158200A (es) Procedimiento para preparar dimetileter
ES512913A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
AR226634A1 (es) Procedimiento para preparar cligolaldehido
ES502851A0 (es) Procedimiento para preparar n6-adenosina
AR227697A1 (es) Procedimiento para la preparacion de 3,4-bis-sustituido 1,2,5,-oxadiazol-2-oxidos
ES500738A0 (es) Procedimiento para preparar pirimidil-quinazolinas
ES544792A0 (es) Procedimiento para preparar colorantes monoazoicos o diazoi-cos
ES500618A0 (es) Procedimiento para la preparacion de 2,3-dicloro-2-trifluo- rometil-1,1,1,3,4,4,5,5,5,-nonafluoropentano
MX6807E (es) Procedimiento para preparar oxaquinolicidinas
MX6699E (es) Procedimiento para preparar acil-ureas
MX7052E (es) Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas
AR225346A1 (es) Procedimiento para preparar sales de 4'-(9-acridinilamino)metansulfon-c-anisidida
ES502356A0 (es) Procedimiento para preparar colorantes bisazoicos
AR226337A1 (es) Procedimiento para preparar kijanimicina
MX6900E (es) Procedimiento para la preparacion de n-(halogenometil)acilamidas
AR227304A1 (es) Procedimiento para preparar tiazoles
ES498762A0 (es) Procedimiento para preparar benzonitrilos sustuituidos
ES503313A0 (es) Procedimiento para preparar butirotiolactonas
ES508259A0 (es) "procedimiento para preparar tiocarnitinas".
ES503535A0 (es) Procedimiento para preparar colorantes monoazoicos dispersos
ES498881A0 (es) Procedimiento para preparar carnitinamidas
ES505478A0 (es) Procedimiento para la preparacion de 2,5-dimetilhexadieno-2,4